Once cell lines are finally validated, why jeopardize your results with cheap and low-end detection kits that can impact the reproducibility of your experiments?
The discovery and development of next-generation monoclonal antibodies for cancer immunotherapy relies on rapid, information-rich solutions that offer deeper biological insights than current strategies